title: Experience of conducting a phase I safety & acceptability clinical trial of a candidate vaginal microbicide & lessons learned.
authors.forename: Soma
authors.initials: S
authors.lastname: Dutta
authors.forename: Neelam
authors.initials: N
authors.lastname: Joglekar
authors.forename: Smita
authors.initials: S
authors.lastname: Joshi
authors.forename: J Reynolds
authors.initials: JR
authors.lastname: Steven
mesh_terms: D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007194:India; D009282:Naphthalenesulfonates / Q000627:therapeutic use*; D011108:Polymers / Q000627:therapeutic use*; D011795:Surveys and Questionnaires; D014623:Vaginal Diseases / Q000188:drug therapy* / Q000382:microbiology*
chemical_list: D000891:Anti-Infective Agents, Local; D009282:Naphthalenesulfonates; C120231:PRO 2000; D011108:Polymers